MCHX
Marchex, Inc.
MCHX's outlook is improving, though it still trails on the overall score.
TMUS
T-Mobile US, Inc.
TMUS has the edge over MCHX overall, supported by stronger valuation and stronger modeled upside.
MCHX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
MCHX's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MCHX PE Valuation
MCHX has no meaningful PE right now: it lost money over the past year.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
MCHX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for MCHX, with profitability improving.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TMUS, with profitability improving.
MCHX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.15 | — |
| Q2 2026 | -$0.12 | -$0.02 |
| Q1 2026 | -$0.11 | +$0.01 |
| Q4 2025 | -$0.11 | $0.00 |
| Q3 2025 | -$0.10 | -$0.01 |
| Q2 2025 | -$0.10 | +$0.01 |
| Q1 2025 | -$0.12 | +$0.03 |
| Q4 2024 | -$0.11 | +$0.11 |
| Q3 2022 | -$0.14 | +$0.02 |
MCHX is still losing money, but less than at its worst: $0.12 per share over the past year, against $0.22 at its worst in late 2023.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the edge over MCHX on earnings quality, reporting a profit while its opponent remains loss making.
MCHX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11M | -5.6% |
| Q1 2026 | $10.6M | -6.9% |
| Q4 2025 | $10.8M | -9% |
| Q3 2025 | $11.5M | -8.3% |
| Q2 2025 | $11.7M | -3.5% |
| Q1 2025 | $11.4M | -1.5% |
| Q4 2024 | $11.9M | -3.8% |
| Q3 2024 | $12.6M | -1.8% |
MCHX's revenue has slid since its 2019 peak: $11M last quarter, down 5.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -3.1% | +1.5 points |
| Q1 2026 | -13% | +3.7 points |
| Q4 2025 | -22% | -8.6 points |
| Q3 2025 | -8.2% | -1.6 points |
| Q2 2025 | -4.6% | +1.4 points |
| Q1 2025 | -16% | -5.1 points |
| Q4 2024 | -13% | -4.3 points |
| Q3 2024 | -6.6% | +3.8 points |
MCHX's operating margin was −3.1% last quarter, up 1.5 points from the same quarter a year ago, near the top of its range since 2019.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over MCHX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over MCHX on profitability, with a higher operating margin.
MCHX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$651K | -243% |
| Q1 2026 | -$957K | +$2M |
| Q4 2025 | $116K | -84% |
| Q3 2025 | $897K | +351% |
| Q2 2025 | $454K | +1035% |
| Q1 2025 | -$2.9M | -$429K |
| Q4 2024 | $710K | -21% |
| Q3 2024 | $199K | +$579K |
MCHX has burned cash in most quarters: −$595,000 over the past year, against −$2M the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over MCHX on cash generation, producing positive trailing cash flow while its opponent burns cash.
MCHX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +5.5M shares |
| 1 year | 0% | -- |
| 3 years | +3% | +1.4M shares |
| 5 years | +0.1% | +70K shares |
| Available history | -3.5% | -1.7M shares |
MCHX has 49M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over MCHX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
MCHX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | -10.9x | Net Cash |
| Q1 2022 | -5.4x | Net Cash |
| Q4 2021 | -27.6x | Net Cash |
| Q4 2019 | -28.7x | Net Cash |
| Q3 2019 | -23.5x | Net Cash |
MCHX has more cash than debt.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
MCHX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 26.9 | Neutral |
MCHX's weekly RSI is 44 (neutral) and its Stochastic is 27 (neutral).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
MCHX PE vs Communication Services Sector
MCHX has no meaningful PE right now: it lost money over the past year.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
MCHX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 4.5% above |
| 20 week MA | $1.55 | 11% below |
| 50 week MA | $1.58 | 13% below |
| 100 week MA | $1.71 | 19% below |
| 200 week MA | $1.69 | 18% below |
MCHX has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 18% below its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.
MCHX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.77 | $2.15 | -43% |
| 2021 | $2.15 | $2.71 | +26% |
| 2022 | $2.71 | $1.71 | -37% |
| 2023 | $1.71 | $1.36 | -20% |
| 2024 | $1.36 | $1.88 | +38% |
| 2025 | $1.88 | $1.67 | -11% |
| 2026 YTD | $1.67 | $1.38 | -17% |
MCHX has finished lower in four of the last six years. It's down 17% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over MCHX on returns for 2026, with the stronger performance.